Registration of securities issued in business combination transactions

RESTATEMENT (Tables)

v3.21.2
RESTATEMENT (Tables)
4 Months Ended
Dec. 31, 2020
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
Schedule of restatement impact

    

As Previously Reported

    

  Adjustments

    

  As Restated

Balance sheet as of December 7, 2020

Warrant liabilities

$

$

43,147,500

$

43,147,500

Total liabilities

12,683,050

43,147,500

55,830,550

Ordinary shares subject to possible redemption

 

329,793,740

 

(43,147,500)

 

286,466,240

Class A ordinary shares

 

152

 

432

 

584

Accumulated deficit

 

(5,000)

 

(1,583,878)

 

(1,588,878)

Additional paid-in-capital

 

5,003,995

 

1,583,447

 

6,587,441

Total Shareholder’s Equity

 

5,000,010

 

 

5,000,010

Balance sheet as of December 31, 2020

 

  

 

  

 

  

Warrant liabilities

$

$

43,147,500

$

43,147,500

Total liabilities

12,779,640

43,147,500

55,927,140

Ordinary shares subject to possible redemption

 

329,615,170

 

(43,147,500)

 

286,467,670

Class A ordinary shares

 

154

 

431

 

585

Accumulated deficit

 

(183,573)

 

(1,583,878)

 

(1,767,451)

Additional paid-in-capital

 

5,182,563

 

1,583,447

 

6,766,010

Total Shareholder's Equity

 

5,000,007

 

 

5,000,007

Net loss from September 11, 2020 to December 31, 2020

 

  

 

  

 

  

Transaction costs allocated to warrant liabilities

$

$

1,583,878

$

1,583,878

Net loss

 

(183,573)

 

(1,583,878)

 

(1,767,451)

Basic and diluted net loss per share, Class B

(0.02)

(0.21)

(0.23)

Cash flow from September 11, 2020 to December 31, 2020

 

  

 

  

 

  

Transaction costs allocated to warrant liabilities

$

$

1,583,878

$

1,583,878

Net loss

 

(183,573)

 

(1,583,878)

 

(1,767,451)